Brüggenwirth IMA - Search Results

1

The Emerging Role of Viability Testing During Liver Machine Perfusion.

Brüggenwirth IMA, van Leeuwen OB, Porte RJ, Martins PN. Brüggenwirth IMA, et al. Liver Transpl. 2022 May;28(5):876-886. doi: 10.1002/lt.26092. Epub 2021 Jun 24. Liver Transpl. 2022. PMID: 33963657 Review.

2

Machine Perfusion: Cold versus Warm, versus Neither. Update on Clinical Trials.

Bonaccorsi-Riani E, Brüggenwirth IMA, Buchwald JE, Iesari S, Martins PN. Bonaccorsi-Riani E, et al. Among authors: bruggenwirth ima. Semin Liver Dis. 2020 Aug;40(3):264-281. doi: 10.1055/s-0040-1713118. Epub 2020 Jun 18. Semin Liver Dis. 2020. PMID: 32557478 Review.

3

Is single portal vein perfusion the best approach for machine preservation of liver grafts?

Brüggenwirth IMA, Burlage LC, Porte RJ, Martins PN. Brüggenwirth IMA, et al. J Hepatol. 2016 May;64(5):1194-1195. doi: 10.1016/j.jhep.2015.12.025. Epub 2016 Feb 1. J Hepatol. 2016. PMID: 26836281 No abstract available.

4

Single-Center Experience With Liver Transplant Using Donors With Very High Transaminase Levels.

Martins PN, Rawson A, Movahedi B, Brüggenwirth IMA, Dolgin NH, Martins AB, Mahboub P, Bozorgzadeh A. Martins PN, et al. Among authors: bruggenwirth ima. Exp Clin Transplant. 2019 Aug;17(4):498-506. doi: 10.6002/ect.2017.0172. Epub 2018 Aug 17. Exp Clin Transplant. 2019. PMID: 30119618 Free article.

5

A Comparative Study of Single and Dual Perfusion During End-ischemic Subnormothermic Liver Machine Preservation.

Brüggenwirth IMA, Moore C, Mahboub P, Thijssen MF, E X, Leuvenink HGD, Mandrekar P, Wang X, Kowalik TF, Porte RJ, Martins PN. Brüggenwirth IMA, et al. Transplant Direct. 2018 Oct 23;4(11):e400. doi: 10.1097/TXD.0000000000000840. eCollection 2018 Nov. Transplant Direct. 2018. PMID: 30534591 Free PMC article.

6

Gene Silencing With siRNA (RNA Interference): A New Therapeutic Option During Ex Vivo Machine Liver Perfusion Preservation.

Thijssen MF, Brüggenwirth IMA, Gillooly A, Khvorova A, Kowalik TF, Martins PN. Thijssen MF, et al. Among authors: bruggenwirth ima. Liver Transpl. 2019 Jan;25(1):140-151. doi: 10.1002/lt.25383. Liver Transpl. 2019. PMID: 30561891 Review.

7

RNA interference therapeutics in organ transplantation: The dawn of a new era.

Brüggenwirth IMA, Martins PN. Brüggenwirth IMA, et al. Am J Transplant. 2020 Apr;20(4):931-941. doi: 10.1111/ajt.15689. Epub 2019 Dec 1. Am J Transplant. 2020. PMID: 31680428 Free article. Review.

8

Bile Composition as a Diagnostic and Prognostic Tool in Liver Transplantation.

Brüggenwirth IMA, Porte RJ, Martins PN. Brüggenwirth IMA, et al. Liver Transpl. 2020 Sep;26(9):1177-1187. doi: 10.1002/lt.25771. Epub 2020 Jul 11. Liver Transpl. 2020. PMID: 32246581 Review.

9

Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study.

Brüggenwirth IMA, van Reeven M, Vasiliauskaitė I, van der Helm D, van Hoek B, Schaapherder AF, Alwayn IPJ, van den Berg AP, de Meijer VE, Darwish Murad S, Polak WG, Porte RJ. Brüggenwirth IMA, et al. Transpl Int. 2021 Jan;34(1):110-117. doi: 10.1111/tri.13770. Epub 2020 Nov 5. Transpl Int. 2021. PMID: 33067844 Free PMC article.

10

Viability criteria assessment during liver machine perfusion.

Brüggenwirth IMA, de Meijer VE, Porte RJ, Martins PN. Brüggenwirth IMA, et al. Nat Biotechnol. 2020 Nov;38(11):1260-1262. doi: 10.1038/s41587-020-0720-z. Epub 2020 Oct 26. Nat Biotechnol. 2020. PMID: 33106683 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters